Covered recipient · General Payments record
THOMAS R CASTIGLIA
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$1,932.91
- Reported across 86 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $362.44 | 17 |
| Education | $19.62 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $113.40 | 6 |
| GlaxoSmithKline, LLC. | $64.11 | 3 |
| Amgen Inc. | $49.57 | 2 |
| PFIZER INC. | $45.93 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $40.69 | 2 |
| Novo Nordisk AS | $39.81 | 2 |
| Exact Sciences Corporation | $28.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $21.91 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117522435 | CMS |
| Amgen Inc. | $27.66 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117522437 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $19.62 | 10/29/2024 | Education | Undisputed | 01/23/2026 | 1086170816 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $21.07 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086198332 | CMS |
| Exact Sciences Corporation | $28.55 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114610030 | CMS |
| GlaxoSmithKline, LLC. | $20.98 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115979667 | CMS |
| GlaxoSmithKline, LLC. | $22.86 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116319210 | CMS |
| GlaxoSmithKline, LLC. | $20.27 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116307815 | CMS |
| Lilly USA, LLC | $24.83 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135463818 | CMS |
| Lilly USA, LLC | $16.13 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135463816 | CMS |
| Lilly USA, LLC | $19.89 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135479052 | CMS |
| Lilly USA, LLC | $18.57 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135479054 | CMS |
| Lilly USA, LLC | $15.71 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135495164 | CMS |
| Lilly USA, LLC | $18.27 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135438238 | CMS |
| Novo Nordisk Inc | $17.94 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097027819 | CMS |
| Novo Nordisk Inc | $21.87 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096947054 | CMS |
| PFIZER INC. | $22.41 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132008246 | CMS |
| PFIZER INC. | $23.52 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131949228 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.